Hermetica Superfood Encyclopedia
The Short Answer
Kauloa contains flavonoids (rutin, quercetin, kaempferol), saponins, and phenolic acids that exert antioxidant, anti-inflammatory, and dopamine D2 receptor-inhibitory actions. In vitro studies demonstrate that its ethanol root extract reduces nitric oxide production by 60–70% in LPS-stimulated macrophages via NF-κB/MAPK pathway suppression, while molecular docking identifies kaempferol and myricetin as D2R inhibitors with binding energies of −5.52 to −6.40 kcal/mol relevant to lactogenic activity.
CategoryHerb
GroupPacific Islands
Evidence LevelPreliminary
Primary Keywordkauloa benefits
Kauloa — botanical close-up
Health Benefits
**Expectorant and Cold Relief**
Tongan traditional use centers on leaf decoctions for upper respiratory infections and colds; saponin constituents are hypothesized to reduce mucus viscosity and stimulate mucociliary clearance, consistent with the expectorant pharmacology documented across saponin-rich Araliaceae species.
**Anti-inflammatory Activity**
Ethanol root extract (EEPS) suppresses NO production by 60–70% and downregulates TNF-α, IL-6, IL-1β, and IL-12 in LPS-stimulated RAW 264.7 macrophages through inhibition of the MAPK and NF-κB signaling cascades, providing a mechanistic basis for its traditional use in inflammatory conditions.
**Antioxidant Protection**: Total phenolic content reaches up to 289
813 ± 11.381 mg GAE/g in ethyl acetate fractions, and DPPH radical scavenging IC50 values of 46.28 μg/mL (ethanol extract) indicate moderate-to-strong free radical neutralization capacity that may protect cells from oxidative stress.
**Lactogenic Support**
Flavonoids kaempferol, myricetin, and quercetin competitively inhibit the dopamine D2 receptor (binding energies −5.52 to −6.40 kcal/mol in silico), a mechanism that reduces dopamine-mediated suppression of prolactin secretion and underpins traditional use of the plant to enhance breast milk production in lactating women.
**Antimicrobial Defense**
Phytochemical constituents including saponins, flavonoids, and phenolic acids disrupt microbial membrane integrity and inhibit cell wall synthesis against selected bacterial and fungal pathogens, though antifungal MIC values exceeding 6400 μg/mL for certain strains suggest species-dependent potency.
**Potential Anticancer Effects**
Kaempferol and related flavonols bind the anti-apoptotic Bcl-2 protein with docking energies of −6.02 to −6.40 kcal/mol in cervical cancer in silico models, suggesting a pro-apoptotic mechanism; however, this evidence remains entirely computational and requires experimental validation.
**Nutritional Micronutrient Delivery**
Leaves provide meaningful quantities of vitamin C (29–83 mg per serving equivalent), calcium (474–540 mg), phosphorus (49–82 mg), and iron (4.0–6.2 mg), supporting immune function, bone mineralization, and oxygen transport alongside its phytochemical activity.
Origin & History
Natural habitat
Polyscias scutellaria is native to Southeast Asia and the Pacific Islands, including Tonga, Fiji, and Indonesia, where it thrives in tropical lowland environments with high humidity and well-drained soils. It is cultivated as an ornamental and medicinal shrub across Pacific Island communities, often growing near dwellings for easy access to its leaves and roots. In Tongan and broader Polynesian tradition, the plant is harvested fresh, with leaves used in decoctions and roots collected for more concentrated preparations.
“In Tongan traditional medicine, kauloa leaves are prepared as warm decoctions and administered to individuals suffering from colds, coughs, and chest congestion, with the saponin-rich leaf material believed to loosen mucus and facilitate its expulsion. Across Southeast Asia and Pacific Island cultures including Fiji, Indonesia, and the Philippines, Polyscias scutellaria occupies a prominent role as a galactagogue, with postpartum women consuming leaf and root teas to stimulate and sustain breast milk production—a practice that modern molecular docking research links to D2 receptor inhibition. The plant is also valued ornamentally throughout its range, cultivated in home gardens where its distinctive shield-shaped or scutellate leaves serve both decorative and ready medicinal functions. Historical use spans at least several generations in Polynesian communities, and the plant features in regional ethnobotanical surveys documenting Araliaceae species in Pacific Island pharmacopoeias.”Traditional Medicine
Scientific Research
The current evidence base for Kauloa is limited to in vitro, in silico, and phytochemical characterization studies; no peer-reviewed human clinical trials have been published as of the available literature. In vitro work using RAW 264.7 macrophage models quantified 60–70% reductions in NO production from ethanol root extracts, and DPPH assays established antioxidant IC50 values of 46.28 μg/mL, providing reproducible but non-clinical benchmarks. Molecular docking analyses using LC-HRMS-identified flavonoids against D2R, 5-HT2AR, and Bcl-2 targets generated binding energy data (−5.52 to −6.40 kcal/mol) that are hypothesis-generating but require validation in cell-based and animal models before clinical relevance can be inferred. LC-HRMS profiling across Polyscias genus extracts confirmed approximately 97 compounds, with P. scutellaria specifically yielding 6–9 flavonoids, 5 terpenes, 7 phenolic acids, and 1 lignan, establishing chemical identity but not pharmacokinetic or pharmacodynamic parameters in living systems.
Preparation & Dosage
Traditional preparation
**Traditional Leaf Decoction (Tongan)**
Fresh or dried leaves are simmered in water for 10–15 minutes to produce a tea consumed 1–2 times daily for cold and respiratory symptoms; no standardized dose established.
**Ethanol Root Extract (Research Grade)**
Used at unspecified doses in RAW 264.7 macrophage studies to achieve 60–70% NO reduction; no human-equivalent dose has been extrapolated.
**Ethyl Acetate Fraction**
813 mg GAE/g) and is used in laboratory antioxidant assays; not available as a commercial supplement form
Yields the highest total phenolic content (up to 289..
**Aqueous or 70% Ethanolic Extract**
49 mg GAE/g phenolics and 58
Produces 16.35–24..42–63.66 mg QE/g flavonoids; represents a preparation closest to traditional aqueous decoctions.
**Standardization**
No commercial standardization percentages for flavonoids or saponins have been established; pharmaceutical-grade preparations do not currently exist.
**Timing**
Traditional preparations are taken acutely during illness episodes; lactogenic use is typically daily throughout the breastfeeding period per ethnobotanical accounts.
Nutritional Profile
Kauloa leaves contain notable concentrations of vitamin C (29–83 mg per unspecified serving unit), calcium (474–540 mg), phosphorus (49–82 mg), and iron (4.0–6.2 mg), positioning them as a mineral-dense leafy green by Pacific Island dietary standards. The dominant phytochemical classes are flavonoids (1.83–63.66 mg QE/g depending on extraction solvent) and phenolics (14.67–289.813 mg GAE/g), with the wide range reflecting solvent polarity effects on extraction efficiency. Saponins are present as a structurally diverse class consistent with other Polyscias species and contribute both bitter taste and bioactivity. Alkaloids, glycosides, terpenes (including oleanolic acid and (−)-caryophyllene oxide), and lignans are detected in smaller quantities. No macronutrient (protein, fat, carbohydrate) compositional data have been published in the peer-reviewed literature for this specific species, and bioavailability of key flavonoids such as rutin and quercetin remains unstudied in the context of this plant.
How It Works
Mechanism of Action
The primary anti-inflammatory mechanism involves saponin-enriched ethanol root extracts suppressing LPS-induced activation of NF-κB and MAPK signaling cascades in macrophages, thereby reducing inducible nitric oxide synthase (iNOS) expression and downstream NO, TNF-α, IL-6, IL-1β, and IL-12 production by 60–70%. Flavonoids—particularly kaempferol, myricetin, and quercetin—function as competitive inhibitors of the dopamine D2 receptor and exhibit binding affinity for the serotonin 5-HT2A receptor, as modeled by molecular docking, providing a plausible galactagogue mechanism through disinhibition of pituitary prolactin release. Phenolic acids and flavonols contribute electron donation and hydrogen atom transfer reactions that neutralize reactive oxygen species, with the high total phenolic content of ethyl acetate fractions (up to 289.813 mg GAE/g) underpinning measured DPPH IC50 values in the 46 μg/mL range. Additionally, kaempferol's in silico interaction with the Bcl-2 anti-apoptotic protein suggests a secondary pro-apoptotic pathway in cancer cell lines, though this requires wet-laboratory and in vivo corroboration.
Clinical Evidence
No controlled human clinical trials have evaluated Kauloa or Polyscias scutellaria for any health outcome, representing a critical evidence gap. Preclinical data establish anti-inflammatory and antioxidant activity in cell culture models, and in silico docking supports lactogenic and potential anticancer hypotheses, but effect sizes in humans are entirely unknown. Traditional ethnobotanical reports from Tonga and other Pacific Island communities document consistent use for respiratory ailments and lactation support, lending biological plausibility that warrants formal clinical investigation. Confidence in therapeutic recommendations remains very low; current evidence supports only exploratory research rather than clinical guidance.
Safety & Interactions
Formal toxicology studies for Polyscias scutellaria are absent from the published literature, and no maximum tolerated dose or NOAEL has been established in any animal or human study. At anti-inflammatory concentrations used in RAW 264.7 cell assays, the ethanol root extract demonstrated no cytotoxicity, and the antifungal MIC exceeding 6400 μg/mL for certain strains suggests the extract has a relatively low non-specific cytotoxic profile; however, these observations do not constitute a validated safety assessment. Theoretical drug interaction concerns arise from the flavonoid-mediated dopamine D2 receptor inhibition, which could antagonize dopamine agonists (e.g., cabergoline, bromocriptine) or potentiate dopamine-depleting agents, and from 5-HT2A receptor binding that may interact with serotonergic medications including SSRIs and atypical antipsychotics—though none of these interactions have been tested empirically. Use during pregnancy should be approached with caution given the galactagogue and receptor-modulating activity; women taking medications for Parkinson's disease, hyperprolactinemia, or psychiatric conditions should consult a healthcare provider before use.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Polyscias scutellariaBowl leafShield araliaKauloa (Tongan)Aralia scutellaria
Frequently Asked Questions
What is kauloa used for in traditional Tongan medicine?
In Tongan traditional medicine, kauloa leaves are prepared as a warm decoction and consumed to relieve colds, coughs, and chest congestion. The saponin-rich leaves are believed to act as expectorants, loosening mucus in the respiratory tract, while the broader Pacific Island tradition also uses the plant to promote breast milk production in postpartum women.
Does Polyscias scutellaria really increase breast milk production?
In silico molecular docking studies show that kauloa flavonoids—kaempferol, myricetin, and quercetin—bind the dopamine D2 receptor with energies of −5.52 to −6.40 kcal/mol, a mechanism that would theoretically reduce dopamine's suppression of prolactin and thereby increase milk production. However, no human clinical trials have tested this effect, so evidence remains computational and ethnobotanical; women seeking lactation support should discuss options with a healthcare provider.
What are the main bioactive compounds in kauloa leaves?
Kauloa leaves and roots are richest in flavonoids—including rutin, quercetin, kaempferol, myricetin, luteolin, and apigenin—along with phenolic acids, saponins, oleanolic acid, terpenes, alkaloids, and lignans. LC-HRMS profiling of Polyscias scutellaria extracts has confirmed at least 6–9 distinct flavonoids, 7 phenolic acids, 5 terpenes, and 1 lignan, with total phenolic content reaching up to 289.813 mg GAE/g in ethyl acetate fractions.
Are there any safety concerns or drug interactions with kauloa?
No formal toxicity studies have been conducted on Polyscias scutellaria, so a comprehensive safety profile is not established. Theoretical concerns include potential antagonism of dopamine agonist medications (such as cabergoline or bromocriptine) due to D2 receptor binding activity, and possible interactions with serotonergic drugs due to 5-HT2A receptor affinity identified in docking models. Individuals taking dopaminergic or serotonergic medications should consult a clinician before use.
What does the scientific research say about kauloa's anti-inflammatory effects?
In vitro studies using LPS-stimulated RAW 264.7 macrophages demonstrated that the ethanol root extract of Polyscias scutellaria reduces nitric oxide production by 60–70% and lowers TNF-α, IL-6, IL-1β, and IL-12 levels through inhibition of NF-κB and MAPK signaling pathways. These are cell culture results only; no animal studies or human trials have confirmed anti-inflammatory efficacy, so clinical applicability cannot yet be determined.
What is the most effective form of kauloa for respiratory support — fresh leaf decoction, dried leaf, or extract?
Traditional Tongan medicine primarily uses fresh or dried leaf decoctions, which allow saponins and other bioactive compounds to extract into water and reach the respiratory tract effectively. Dried leaf decoctions are more practical for consistent dosing and storage, while fresh preparations may retain volatile components; standardized extracts have not been widely studied for respiratory applications compared to the traditional decoction method. The hot-water extraction process used in decoctions is well-suited to releasing saponin constituents responsible for the hypothesized expectorant effect.
Is kauloa safe to use during pregnancy or while breastfeeding?
While kauloa is traditionally used in Tongan medicine to support lactation, safety data specifically during pregnancy is limited and should be discussed with a healthcare provider before use. The saponin content and other bioactive compounds have not been extensively studied in pregnant populations, making precautionary avoidance advisable unless under professional guidance. Breastfeeding women considering kauloa should consult with a midwife or lactation specialist, as traditional use does not guarantee safety in modern clinical contexts.
How does kauloa compare to other saponin-rich herbs like ginseng or fenugreek for expectorant effects?
Kauloa's saponin-rich profile is shared with ginseng and fenugreek, but kauloa is specifically documented in Tongan traditional medicine for upper respiratory infections and mucus clearance, whereas ginseng is primarily studied for immune support and fenugreek for lactation. The saponin structure and concentration differ among these plants, potentially affecting bioavailability and expectorant potency, though direct comparative clinical trials are lacking. Kauloa's traditional use pattern suggests it may be particularly suited for acute cold and respiratory symptoms rather than the immune-modulation or digestive support for which ginseng and fenugreek are better researched.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w kauloa-polyscias-scutellaria curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
